1. S. Taillibert, C. Chodkiewicz, F. Laigle-Donadey, M. Napolitano, S. Cartalat-Carel, and M. Sanson. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol, 76(2):201-5, 2006. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Brain Neoplasms/epidemiology/*pathology/therapy, Child, Child, Preschool, Combined Modality Therapy, Databases, Factual, Female, France/epidemiology, Humans, Infant, Karnofsky Performance Status, Male, Middle Aged, Neoplasms, Neuroepithelial/epidemiology/*pathology/therapy, Prognosis, Registries, Sex Factors, Survival Analysis, Tomography, X-Ray Computed.



2. M. Sanson, S. Cartalat-Carel, S. Taillibert, M. Napolitano, L. Djafari, J. Cougnard, H. Gervais, F. Laigle, A. Carpentier, K. Mokhtari, L. Taillandier, O. Chinot, H. Duffau, J. Honnorat, K. Hoang-Xuan, and J. Y. Delattre. Initial chemotherapy in gliomatosis cerebri. Neurology, 63(2):270-5, 2004. Note: ANOCEF groupClinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/adverse effects/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration &, dosage/adverse effects/*therapeutic use, Astrocytoma/drug therapy/radiotherapy, Brain Neoplasms/*drug therapy/pathology/radiotherapy, Combined Modality Therapy, Cranial Irradiation, Dacarbazine/adverse effects/*analogs & derivatives/*therapeutic use, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Female, Hematologic Diseases/chemically induced, Humans, Karnofsky Performance Status, Lomustine/administration & dosage/adverse effects, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/pathology/radiotherapy, Oligodendroglioma/drug therapy/radiotherapy, Procarbazine/administration & dosage/adverse effects, Survival Analysis, Treatment Outcome, Vincristine/administration & dosage/adverse effects.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html